Dealing in securities by directors and prescribed officers: vesting of shares and settlement by on market sales and equity settlement
Johannesburg, Thursday, 27 October 2022. In compliance with paragraphs 3.63 to 3.74 of the JSE Listings Requirements, the following dealings in securities by directors and prescribed officers of Harmony in relation to the vesting and settlement of deferred share awards made pursuant to the provisions of the Harmony Deferred Share Plan 2018 are disclosed:
| 1. | Name of director: | PW Steenkamp (Chief Executive Officer) |
| Nature of transaction: | Vesting of deferred share awards and settlement by on-market sale of shares, in terms of the Harmony Deferred Share Plan 2018 | |
| Vesting Date: | 18 September 2022 | |
| Class of securities: | Ordinary shares | |
| Number of ordinary shares vested: | 192 557 | |
| Number of ordinary shares locked up towards minimum shareholding requirement: | 39 493 | |
| Number of vested shares sold on market: | 153 064 | |
| Date of conclusion of bulk on-market sale of shares: | 21 October 2022 | |
| On-market sale price per share: | Volume weighted average price of R47.41 per share (with a low of R46.66 per share and a high of R48.25 per share) | |
| Total value of shares sold on market prior to deduction of tax liability: | R7 256 764 | |
| Number of shares retained in own name: | 0 | |
| Total value of shares retained in own name: | R0 | |
| Nature and extent of prescribed officer’s interest: | Direct beneficial | |
| 2. | Name of director: | BP Lekubo (Financial Director) |
| Nature of transaction: | Vesting of deferred share awards and settlement by on-market sale of shares, in terms of the Harmony Deferred Share Plan 2018 | |
| Vesting Date: | 18 September 2022 | |
| Class of securities: | Ordinary shares | |
| Number of ordinary shares vested: | 44 704 | |
| Number of ordinary shares locked up towards minimum shareholding requirement: | 19 004 | |
| Number of vested shares sold on market: | 25 700 | |
| Date of conclusion of bulk on-market sale of shares: | 21 October 2022 | |
| On-market sale price per share: | Volume weighted average price of R47.41 per share (with a low of R46.66 per share and a high of R48.25 per share) | |
| Total value of shares sold on market prior to deduction of tax liability: | R1 218 437 | |
| Number of shares retained in own name: | 0 | |
| Total value of shares retained in own name: | R0 | |
| Nature and extent of prescribed officer’s interest: | Direct beneficial | |
| 3. | Name of director: | HE Mashego (Executive Director) |
| Nature of transaction: | Vesting of deferred share awards and settlement by on-market sale of shares, in terms of the Harmony Deferred Share Plan 2018 | |
| Vesting Date: | 18 September 2022 | |
| Class of securities: | Ordinary shares | |
| Number of ordinary shares vested: | 36 202 | |
| Number of ordinary shares locked up towards minimum shareholding requirement: | 18 100 | |
| Number of vested shares sold on market: | 18 102 | |
| Date of conclusion of bulk on-market sale of shares: | 21 October 2022 | |
| On-market sale price per share: | Volume weighted average price of R47.41 per share (with a low of R46.66 per share and a high of R48.25 per share) | |
| Total value of shares sold on market prior to deduction of tax liability: | R858 216 | |
| Number of shares retained in own name: | 0 | |
| Total value of shares retained in own name: | R0 | |
| Nature and extent of prescribed officer’s interest: | Direct beneficial | |
| 4. | Name of prescribed officer: | B Nel |
| Nature of transaction: | Vesting of deferred share awards and settlement by on-market sale of shares, in terms of the Harmony Deferred Share Plan 2018 | |
| Vesting Date: | 18 September 2022 | |
| Class of securities: | Ordinary shares | |
| Number of ordinary shares vested: | 36 840 | |
| Number of ordinary shares locked up towards minimum shareholding requirement: | 18 419 | |
| Number of vested shares sold on market: | 18 421 | |
| Date of conclusion of bulk on-market sale of shares: | 21 October 2022 | |
| On-market sale price per share: | Volume weighted average price of R47.41 per share (with a low of R46.66 per share and a high of R48.25 per share) | |
| Total value of shares sold on market prior to deduction of tax liability: | R873 340 | |
| Number of shares retained in own name: | 0 | |
| Total value of shares retained in own name: | R0 | |
| Nature and extent of prescribed officer’s interest: | Direct beneficial | |
| 5. | Name of prescribed officer: | M van der Walt |
| Nature of transaction: | Vesting of deferred share awards and settlement by on-market sale of shares, in terms of the Harmony Deferred Share Plan 2018 | |
| Vesting Date: | 18 September 2022 | |
| Class of securities: | Ordinary shares | |
| Number of ordinary shares vested: | 34 689 | |
| Number of ordinary shares locked up towards minimum shareholding requirement: | 9 870 | |
| Number of vested shares sold on market to cover tax: | 11 540 | |
| Date of conclusion of bulk on-market sale of shares: | 21 October 2022 | |
| On-market sale price per share: | Volume weighted average price of R47.41 per share (with a low of R46.66 per share and a high of R48.25 per share) | |
| Total value of shares sold on market to cover tax: | R547 111 | |
| Number of shares retained in own name: | 13 279 | |
| Total value of shares retained in own name: | R629 557 | |
| Nature and extent of prescribed officer’s interest: | Direct beneficial | |
| 6. | Name of prescribed officer: | J van Heerden |
| Nature of transaction: | Vesting of deferred share awards and settlement by on-market sale of shares, in terms of the Harmony Deferred Share Plan 2018 | |
| Vesting Date: | 18 September 2022 | |
| Class of securities: | Ordinary shares | |
| Number of ordinary shares vested: | 47 734 | |
| Number of ordinary shares locked up towards minimum shareholding requirement: | 23 866 | |
| Number of vested shares sold on market: | 23 868 | |
| Date of conclusion of bulk on-market sale of shares: | 21 October 2022 | |
| On-market sale price per share: | Volume weighted average price of R47.41 per share (with a low of R46.66 per share and a high of R48.25 per share) | |
| Total value of shares sold on market prior to deduction of tax liability: | R1 131 582 | |
| Number of shares retained in own name: | 0 | |
| Total value of shares retained in own name: | R0 | |
| Nature and extent of prescribed officer’s interest: | Direct beneficial | |
| 7. | Name of prescribed officer: | A Buthelezi |
| Nature of transaction: | Vesting of deferred share awards and settlement by on-market sale of shares, in terms of the Harmony Deferred Share Plan 2018 | |
| Vesting Date: | 18 September 2022 | |
| Class of securities: | Ordinary shares | |
| Number of ordinary shares vested: | 31 675 | |
| Number of vested shares sold on market: | 31 675 | |
| Date of conclusion of bulk on-market sale of shares: | 21 October 2022 | |
| On-market sale price per share: | Volume weighted average price of R47.41 per share (with a low of R46.66 per share and a high of R48.25 per share) | |
| Total value of shares sold on market prior to deduction of tax liability: | R1 501 712 | |
| Number of shares retained in own name: | 0 | |
| Total value of shares retained in own name: | R0 | |
| Nature and extent of prescribed officer’s interest: | Direct beneficial | |
| 8. | Name of prescribed officer: | M Naidoo-Vermaak |
| Nature of transaction: | Vesting of deferred share awards and settlement by on-market sale of shares, in terms of the Harmony Deferred Share Plan 2018 | |
| Vesting Date: | 18 September 2022 | |
| Class of securities: | Ordinary shares | |
| Number of ordinary shares vested: | 34 901 | |
| Number of vested shares sold on market: | 34 901 | |
| Date of conclusion of bulk on-market sale of shares: | 21 October 2022 | |
| On-market sale price per share: | Volume weighted average price of R47.41 per share (with a low of R46.66 per share and a high of R48.25 per share) | |
| Total value of shares sold on market prior to deduction of tax liability: | R1 654 656 | |
| Number of shares retained in own name: | 0 | |
| Total value of shares retained in own name: | R0 | |
| Nature and extent of prescribed officer’s interest: | Direct beneficial |
Prior clearance was obtained in respect of the above dealings in securities in compliance with paragraph 3.66 of the JSE Listings Requirements.
Ends.
For more details contact:
Jared Coetzer
Head of Investor Relations
+27 (0) 82 746 4120
Johannesburg, South Africa
27 October 2022
Sponsor:
J.P. Morgan Equities South Africa Proprietary Limited